• Download mobile app
04 Dec 2023, Edition - 3065, Monday

Trending Now

  • AIADMK ends its alliance with the BJP.
  • ED searches are underway at 30 different locations in Tamil Nadu
  • PM Modi distributes appointment letters to the newly inducted recruits during Rozgar Mela.


KMCH adopts Immuno Adsorption method for mismatch kidney transplant, saves teenager

Covai Post Network


An 18-year-old boy was saved after adopting a new Immuno Adsorption method by a city hospital for kidney transplant with incompatible blood group.

The teenager was brought to Kovai Medical Center and Hospital (KMCH) with severe body pain and vomiting and also with difficulty in walking. On evaluation he was found to have a poor kidney function and very low calcium causing severe bone pain and weakness and a kidney transplantation was suggested as his kidneys were shrunk, KMCH Chairman, Nalla G Palanisamy told reporters here today.

Though his mother had the same blood group, she found to be a diabetic and could not donate her kidney and his father’s blood group did not match with the boy preventing taking his kidney also.

With apprehension of various increased risk in transplantation with mismatched blood group in conventional method, the doctors advised Immuno-Adsorption method to do blood group incompatible transplantation, a technology available in Europe, which will remove only the harmful antibodies and nothing else.

“There is no risk of bleeding or infection or replacement of blood products,” consultant nephrologist Dr. Mangalkumar, who led the team of doctors, said.

After completing all the legal work the doctors proceeded with one session of the method, which brought the laboratory parameters safe to proceed with transplantation.

“The boy underwent transplantation the next day and the kidney started working immediately. The boy is doing well with normal kidney function, one month after the surgery and is walking better with no pain and looking forward to go to college in another two months’ time,” Mangalkumar said.

Subscribe To Our Newsletter